Health Condition 1: H25- Age-related cataract Health Condition 2: H28- Cataract in diseases classified elsewhere Health Condition 3: H26- Other cataract
Conditions
Interventions
Intervention1: lidocaine with ropivacine and Hyaluronidase: 2 % lidocaine with 0.75% ropivacine and 15 IU/ml of Hyaluronidase will be administered as an anaesthetic agent in the peribulbar block given
Sponsors
NKP Salve institute of medical sciences and research centre and LMH hospital Nagpur
Eligibility
Inclusion criteria
Inclusion criteria: 1} patients of ASA 1 and 2 2} patients posted for small incision cataract surgery
Exclusion criteria
Exclusion criteria: 1} patients having local sepsis, glaucoma, coagulation abnormality. 2} patient refusal 3} uncooperative patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare efficacy of combination of 2% lidocaine with 0.75% ropivacaine and 2% lidocaine with 0.5% bupivacaine for peribulbar block in patients undergoing cataract surgery with respect to : 1} onset of sensory blockade {in minutes} 2}onset of motor blockade {in minutes} 3} duration of post operative analgesia {in minutes}Timepoint: 1)Post operative pain assessment will be done every half hour for 2 hours and hourly for 6 hours. 2)24 hrs analgesic requirement will be noted | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the combination of 2% lidocaine with 0.75% ropivacaine & 2% lidocaine with 0.5% bupivacaine in patients undergoing cataract surgery under peribulbar block with respect to : 1} hemodynamic stability 2} side effects- nausea, vomitingTimepoint: 1} hemodynamic stability - systolic blood pressure diastolic blood pressure mean arterial blood pressure heart rate oxygen saturation electrocardiogram will be observed from the application of peribulbar block till the end of procedure. 2}side effects- nausea, vomiting will be observed from the application of peribulbar block till the end of procedure. Time of block will be taken as 0 min & patient will be observered at 5 min intervals till end of procedure. | — |
Countries
India
Contacts
Public ContactPrajakta Mehare
NKP Salve institute of medical sciences
Outcome results
None listed